HIV infection

HIV AIDS PREP
Favicon Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

After exposure to lenacapavir, HIV was able to shift the structure of its protein coating to avoid the drug’s effects.
Darren Incorvaia Jan 7, 2026 2:00pm
COVID-19 vaccine

Pfizer, Gilead, GSK to dominate infectious disease market

Jul 20, 2023 9:45am
Champion campaign

Theratechnologies’ ‘Champions’ showcases minority HIV patients

Mar 30, 2023 4:16am
MyHealthTeams

AbbVie top TV drug ad spender in January

Feb 6, 2023 9:45am
HIV

ViiV Healthcare finds HIV stigma still stubbornly high

Dec 2, 2022 9:40am